Stocks and Investing
Stocks and Investing
Tue, February 6, 2024
[ Tue, Feb 06th 2024
] - WOPRAI
[ Tue, Feb 06th 2024
] - WOPRAI
[ Tue, Feb 06th 2024
] - WOPRAI
[ Tue, Feb 06th 2024
] - WOPRAI
[ Tue, Feb 06th 2024
] - WOPRAI
Mon, February 5, 2024
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
[ Mon, Feb 05th 2024
] - WOPRAI
Evan David Seigerman Maintained (ABBV) at Buy with Increased Target to $195 on, Feb 5th, 2024
Evan David Seigerman of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $187 to $195 on, Feb 5th, 2024.
Evan has made no other calls on ABBV in the last 4 months.
There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 2 agree with Evan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Rajesh Kumar of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $156 on, Monday, December 18th, 2023
- James Shin of "Deutsche Bank" Initiated at Hold and Held Target at $150 on, Thursday, November 9th, 2023
These are the ratings of the 3 analyists that currently disagree with Evan
- Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, January 29th, 2024
- Chris Shibutani of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $173 on, Monday, December 11th, 2023
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Monday, October 30th, 2023
Contributing Sources